EP3288583 - NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.07.2021 Database last updated on 24.08.2024 | |
Former | Examination is in progress Status updated on 11.01.2019 | ||
Former | Request for examination was made Status updated on 02.02.2018 | ||
Former | The international publication has been made Status updated on 04.11.2016 | Most recent event Tooltip | 16.07.2021 | Application deemed to be withdrawn | published on 18.08.2021 [2021/33] | Applicant(s) | For all designated states Autolus Limited Forest House 58 Wood Lane London W12 7RZ / GB | [2021/04] |
Former [2019/52] | For all designated states UCL Business Ltd The Network Building 97 Tottenham Court Road London W1T 4TP / GB | ||
Former [2018/10] | For all designated states UCL Business PLC The Network Building 97 Tottenham Court Road London W1T 4TP / GB | Inventor(s) | 01 /
PULÉ, Martin c/o Autolus Ltd Forest House Depot Road London W12 7RP / GB | 02 /
CORDOBA, Shaun c/o Autolus Ltd Forest House Depot Road London W12 7RP / GB | [2018/10] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
Former [2018/10] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 16721212.5 | 26.04.2016 | [2018/10] | WO2016GB51163 | Priority number, date | GB20150007119 | 27.04.2015 Original published format: GB 201507119 | [2018/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016174407 | Date: | 03.11.2016 | Language: | EN | [2016/44] | Type: | A1 Application with search report | No.: | EP3288583 | Date: | 07.03.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.11.2016 takes the place of the publication of the European patent application. | [2018/10] | Search report(s) | International search report - published on: | EP | 03.11.2016 | Classification | IPC: | A61K39/00, C07K14/705, C07K16/28, C07K19/00 | [2018/10] | CPC: |
C07K16/2803 (EP,US);
A61K35/17 (US);
A61K39/0011 (US);
A61K39/461 (EP);
A61K39/4631 (EP);
A61K39/464404 (EP);
A61K39/464411 (EP);
A61K39/464412 (EP);
A61K39/464471 (EP);
A61P35/00 (EP,US);
C07K14/70503 (US);
C07K14/7051 (EP,US);
C07K14/70517 (US);
C07K14/70521 (US);
C07K16/2863 (EP,US);
C07K16/3084 (EP,US);
C12N7/00 (US);
C12N9/16 (EP,US);
C12Y301/03048 (EP,US);
A61K2039/5156 (US);
A61K2239/28 (EP);
C07K2317/622 (EP,US);
C07K2319/02 (EP,US);
C07K2319/03 (US);
C07K2319/033 (EP,US);
C07K2319/04 (US);
C07K2319/05 (US);
C12N2710/10333 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/10] | Title | German: | NUKLEINSÄUREKONSTRUKT ZUR EXPRESSION VON MEHR ALS EINEM CHIMÄREN ANTIGENREZEPTOR | [2018/10] | English: | NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR | [2018/10] | French: | STRUCTURE D'ACIDE NUCLÉIQUE POUR EXPRIMER PLUS D'UN RÉCEPTEUR D'ANTIGÈNE CHIMÈRE | [2018/10] | Entry into regional phase | 27.11.2017 | National basic fee paid | 27.11.2017 | Designation fee(s) paid | 27.11.2017 | Examination fee paid | Examination procedure | 30.10.2017 | Date on which the examining division has become responsible | 27.11.2017 | Examination requested [2018/10] | 13.06.2018 | Amendment by applicant (claims and/or description) | 10.01.2019 | Despatch of a communication from the examining division (Time limit: M04) | 29.04.2019 | Reply to a communication from the examining division | 05.09.2019 | Despatch of a communication from the examining division (Time limit: M06) | 13.03.2020 | Reply to a communication from the examining division | 10.09.2020 | Despatch of a communication from the examining division (Time limit: M06) | 23.03.2021 | Application deemed to be withdrawn, date of legal effect [2021/33] | 14.04.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/33] | Fees paid | Renewal fee | 26.04.2018 | Renewal fee patent year 03 | 29.04.2019 | Renewal fee patent year 04 | 27.04.2020 | Renewal fee patent year 05 | 27.04.2021 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2013063419 (UNIV PENNSYLVANIA [US], et al) [Y] 1-39 * see pages 10-11, 21-26, 31-34 and claims 1-9 and 12-14 *; | [Y]WO2013154760 (US HEALTH [US]) [Y] 1-39 * see pages 3-12 *; | [Y]WO2014127261 (UNIV CALIFORNIA [US]) [Y] 1-39 * see pages 8-22 and claims 1-9 *; | [Y]WO2014145252 (MILONE MICHAEL C [US], et al) [Y] 1-39 * the whole document *; | [Y]WO2015052536 (UCL BUSINESS PLC [GB]) [Y] 1-39 * the whole document *; | [IP]WO2015075470 (UCL BUSINESS PLC [GB]) [IP] 1-39 * the whole document *; | [E]WO2016102965 (UCL BUSINESS PLC [GB], et al) [E] 1-39* the whole document *; | [XY] - ZAKARIA GRADA ET AL, "TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy", MOLECULAR THERAPY-NUCLEIC ACIDS, (20130701), vol. 2, no. 7, doi:10.1038/mtna.2013.32, page e105, XP055152438 [X] 1-4,28-30,32 * the whole document * [Y] 1-39 DOI: http://dx.doi.org/10.1038/mtna.2013.32 | [Y] - V. D. FEDOROV ET AL, "PD-1- and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses", SCIENCE TRANSLATIONAL MEDICINE, (20131211), vol. 5, no. 215, doi:10.1126/scitranslmed.3006597, ISSN 1946-6234, pages 215ra172 - 215ra172, XP055210508 [Y] 1-39 * the whole document * DOI: http://dx.doi.org/10.1126/scitranslmed.3006597 | [Y] - SHAUN CORDOBA ET AL, "Chimeric Antigen Receptor Logical AND Gate Based on CD45/CD148 Phosphatases", MOLECULAR THERAPY, (20140501), vol. 22, no. Suppl. 1, ISSN 1525-0016, page S59, XP055170616 [Y] 1-39 * the whole document * | [Y] - MICHAEL C JENSEN ET AL, "Designing chimeric antigen receptors to effectively and safely target tumors", CURRENT OPINION IN IMMUNOLOGY, (20150123), vol. 33, doi:10.1016/j.coi.2015.01.002, ISSN 0952-7915, pages 9 - 15, XP055217152 [Y] 1-39 * the whole document * DOI: http://dx.doi.org/10.1016/j.coi.2015.01.002 | [Y] - M. SADELAIN ET AL, "The Basic Principles of Chimeric Antigen Receptor Design", CANCER DISCOVERY, US, (20130401), vol. 3, no. 4, doi:10.1158/2159-8290.CD-12-0548, ISSN 2159-8274, pages 388 - 398, XP055287277 [Y] 1-39 * the whole document * DOI: http://dx.doi.org/10.1158/2159-8290.CD-12-0548 | [Y] - M. SHARPE ET AL, "Genetically modified T cells in cancer therapy: opportunities and challenges", DISEASE MODELS & MECHANISMS, GB, (20150401), vol. 8, no. 4, doi:10.1242/dmm.018036, ISSN 1754-8403, pages 337 - 350, XP055288112 [Y] 1-39 * the whole document * DOI: http://dx.doi.org/10.1242/dmm.018036 | by applicant | WO0063372 | US7052906 | WO2013153391 | - LAMERS ET AL., MOL. THER., (2013), vol. 21, pages 904 - 912 | - STAUB ET AL., CELL. SIGNAL., (2004), vol. 16, pages 435 - 456 | - DONNELLY ET AL., J. GEN. VIROL., (2001), vol. 82, pages 1027 - 1041 | - BONIFACINO; TRAUB, ANN. REV. BIOCHEM., (2003), vol. 72, pages 395 - 447 | - BRAULKE; BONIFACINO, BIOCHIMICA AND BIOPHYSICA ACTA, (2009), vol. 1793, pages 605 - 614 | - GRIFFITH, CURRENT BIOLOGY, (2001), vol. 11, pages R226 - R228 | - MELLMAN; NELSON, NAT REV MOL CELL BIOL., (2008), vol. 9, pages 833 - 845 | - DELL'ANGELICA; PAYNE, CELL, (2001), vol. 106, pages 395 - 398 | - SCHAFER ET AL., EMBO J., (1995), vol. 14, pages 2424 - 2435 | - TREJO, MOL. PHARMACOL., (2005), vol. 67, pages 1388 - 1390 | - PELHAM, METH. ENZYMOL., (2000), vol. 327, pages 279 - 283 | - GODER; SPIESS, FEBS LETT, (2001), vol. 504, pages 87 - 93 | - BONIFACINO; TRAUB, ANNU. REV. BIOCHEM., (2003), vol. 72, pages 395 - 447 | - SCHEEL ET AL., J. BIOL. CHEM., (1993), vol. 268, page 7465 | - TEASDALE; JACKSON, ANNU. REV. CELL DEV. BIOL., (1996), vol. 12, page 27 | WO2014GB53452 |